Home
About
Overview
Sharing Data
ORCID
Help
History (66)
Targoff, Ira
IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production.
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials.
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
See All 66 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis.
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med. 1990 May 03; 322(18):1260-4.
View in:
PubMed
subject areas
Acute Disease
Adult
Aged
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Hemorrhage
Heparin
Humans
Injections, Intravenous
Male
Middle Aged
Randomized Controlled Trials as Topic
Recurrence
Thrombophlebitis
Warfarin
authors with profiles
Gary E Raskob